AJ Vaccines Holding ApS
- Adresse
- Artillerivej 5
2300 Copenhagen S - Hjemmeside
- www.ajvaccines.com
- Telefon
- 72 29 70 00
Key activities AJ Vaccines Group (AJV) is a biopharmaceutical Company specializing in the development and manufacturing of vaccines, diagnostics and therapeutic products. Our portfolio includes stand‑alone and combination vaccines for, polio, tuberculosis control, and a treatment for non‑muscle invasive bladder cancer. AJV operates across the full value chain—from early research and development through production to commercialization and global distribution. Via partnerships with strategic collaborators, we seek to expand our commercial footprint while improving global access to vaccines. Our…
Regnskabsår 01.01.2025 – 31.12.2025. Viser koncerntal · vis moderselskab
Regnskab (t.kr.)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Resultatopgørelse | |||||||
| Omsætning | 389.681 | 412.969 | 468.886 | 423.175 | 368.067 | 362.250 | 323.471 |
| Bruttofortjeneste | -220.277 | -587.049 | -30.723 | -64.032 | -300.585 | -311.564 | -224.532 |
| Resultat af primær drift | -459.733 | -767.302 | -206.882 | -231.827 | -460.392 | -442.217 | -357.862 |
| Finansielle indtægter | 26.780 | 605 | 67.873 | 261 | 83.941 | 166.701 | 4.617 |
| Finansielle omkostninger | 38.669 | 38.507 | 153.968 | 292.360 | 357.183 | 125.386 | 112.508 |
| Resultat før skat | -471.622 | -805.204 | -292.977 | -520.062 | -723.909 | -386.528 | -436.514 |
| Skat af årets resultat | 0 | -77 | 469 | -721 | -2.010 | -2.325 | -74.513 |
| Årets resultat | -471.622 | -805.127 | -293.446 | -519.341 | -721.899 | -384.203 | -362.001 |
| Balance | |||||||
| Anlægsaktiver | 373.032 | 378.267 | 910.209 | 924.800 | 980.145 | 1.150.148 | 1.200.474 |
| Omsætningsaktiver | 488.606 | 619.993 | 601.617 | 560.130 | 470.993 | 585.254 | 645.474 |
| Likvide beholdninger | 10.068 | 9.322 | 6.050 | 84.886 | 23.633 | 21.026 | 60.570 |
| Aktiver i alt | 861.638 | 998.260 | 1.511.826 | 1.484.930 | 1.451.138 | 1.735.402 | 1.845.948 |
| Selskabskapital | 535 | 329 | 306 | 108 | 70 | 50 | 50 |
| Overført resultat | -3.527.655 | -3.056.020 | -2.250.904 | -1.956.693 | -1.437.567 | -716.677 | -331.419 |
| Egenkapital | 287.849 | 409.994 | 929.253 | -1.238.217 | -1.188.621 | -716.627 | -331.369 |
| Langfristet gæld | 319.721 | 311.485 | 326.662 | 258.412 | 283.455 | 318.293 | 334.149 |
| Kortfristet gæld | 254.068 | 276.781 | 255.911 | 2.464.735 | 2.356.304 | 2.133.736 | 1.843.168 |
| Nøgletal | |||||||
| Overskudsgrad | -118,0 % | -185,8 % | -44,1 % | -54,8 % | -125,1 % | -122,1 % | -110,6 % |
| Egenkapitalforrentning | -135,2 % | -120,2 % | – | – | – | – | – |
| Soliditetsgrad | 33,4 % | 41,1 % | 61,5 % | -83,4 % | -81,9 % | -41,3 % | -18,0 % |
| Likviditetsgrad | 192 % | 224 % | 235 % | 23 % | 20 % | 27 % | 35 % |
| Antal ansatte | 451 | 581 | 577 | 575 | 577 | 722 | 719 |
Ledelse
- Abdulaziz Abdulhamid Abdulrhman AlbassamDirektion · CEO
- Muhammed Ali A. AlesayiDirektion
- Mustafa Nasir FarookiDirektion
- Saddam Abdulqawi Hussein AlhumaikaniDirektion
- Tarek Sherif Ahmed Abbas HegazyDirektion
Tidligere ledelse (10)
- Abdulaziz Hamad AljomaihBestyrelsesformand · 2022–2022
- Muhammed Ali A. AlesayiBestyrelsesmedlem · 2022–2022
- Mustafa Nasir FarookiBestyrelsesmedlem · 2022–2022
- Saddam Abdulqawi Hussein AlhumaikaniBestyrelsesmedlem · 2022–2022
- Shan-E-Abbas AsharyBestyrelsesmedlem · 2022–2022
- Shan-E-Abbas AsharyDirektion · 2019–2023
- Abdulaziz Hamad AljomaihDirektion · 2020–2021
- Mohammed Ali A. AlesayiDirektion · 2020–2021
- Dr. Tabassum KhanDirektion · 2019–2020
- Abdul Wahab Mohammed A AlesayiDirektion · 2019–2019
Ifølge underskrifterne i årsrapporterne. Personer identificeres ud fra navn.
Revision
- PricewaterhouseCoopers Statsautoriseret RevisionspartnerselskabAuditor's report on audited financial statements · 2019–2025
Seneste erklæring: Auditor's report on audited financial statements
Årsrapporter (9)
| Regnskabsperiode | Dokumenter |
|---|---|
| 01.01.2025 – 31.12.2025 | Årsrapport (HTML) XBRL |
| 01.01.2024 – 31.12.2024 | PDF XBRL |
| 01.01.2023 – 31.12.2023 | PDF XBRL |
| 01.01.2022 – 31.12.2022 | PDF XBRL |
| 01.01.2021 – 31.12.2021 | PDF XBRL |
| 01.01.2020 – 31.12.2020 | PDF XBRL |
| 01.01.2019 – 31.12.2019 | PDF XBRL |
| 01.01.2018 – 31.12.2018 | PDF XBRL |
| 09.01.2017 – 31.12.2017 | PDF XBRL |